von Tobias Borgers | Sep 16, 2019 | Bayer
Bayer completes merger of Monsanto India Times of IndiaIndia Business News: New Delhi, Sep 16 () German chemical and pharma major Bayer AG on Monday said it has completed the integration of biotech major … Link zum...
von Tobias Borgers | Sep 9, 2019 | Kunden
Erst durch integriertes Materialhandling entstehen flexible und automatisierbare Anlagen.Bild: Glatt Einwiegen, Mischen, Sieben, Granulieren, Tablettieren, Beschichten, Verpacken – die Zahl Verfahrensschritte bei der Verarbeitung und Produktion von Solida in der...
von Tobias Borgers | Sep 6, 2019 | Roche
Media Release Basel, 31 January 2019 Roche reports very strong results in 2018 Group sales increase 7%1 at constant exchange rates and in Swiss francs Pharmaceuticals Division sales up 7%, driven mainly by Ocrevus, Perjeta, Tecentriq, Alecensa and Hemlibra Diagnostics...
von Tobias Borgers | Sep 5, 2019 | Roche
Media Release Basel, 25 February 2019 Roche enters into definitive merger agreement to acquire Spark Therapeutics Roche to acquire Spark Therapeutics for US$ 114.50 per share Spark Therapeutics is a leader in discovering, developing and delivering gene therapies with...
von Tobias Borgers | Sep 3, 2019 | Bayer
Bayer hires former J&J executive for more pharma deals ReutersBayer nabs new dealmaker – but after Monsanto, is there enough cash? FierceBiotechBayer appoints Marianne De Backer Head of Pharmaceuticals Business Development &...
von Tobias Borgers | Sep 1, 2019 | Roche
Media Release Basel, 17 April 2019 Roche reports a strong start in 2019 and raises the outlook for the full-year Group sales increase 8%1 at constant exchange rates and 9% in Swiss francs Pharmaceuticals Division sales up 10%, driven mainly by Ocrevus, Perjeta,...
